Skip to main content
. 2015 Dec 16;5(1):e28997. doi: 10.5812/cardiovascmed.28997

Table 1. Baseline Characteristics of Patients According to Tertiles of High-Sensitivity C-Reactive Protein Levels a,b.

Variable Tertile I, < 10 mg/L (n = 223) Tertile II, III, > 10 mg/L (n = 427) P Values
Clinical Characteristics
Age, y 64.39 ± 8.29 63.22 ± 8.56 0.25
Male gender 140 (63) 246 (57.61) 0.23
Body mass index, kg/m2 26.98 (24.01 - 31.18) 26.96 (24.7 - 30.14) 0.50
Diabetes 55 (25) 124 (29) 0.26
Hypertension 44 (20) 111 (26) 0.75
Current smoking 138 (62) 231 (54) 0.057
Dyslipidemia 107 (48) 143 (33.5) 0.54
Clinical indication < 0.001
Elective 175 (78.5) 71 (16.7)
UA 38 (17) 202 (47.3)
NSTEMI 10 (4.5) 111 (26)
STEMI 0 43 (10)
Procedural characteristics < 0.001
One vessel disease 94 (42) 119 (28)
Multivessel disease 129 (58) 308 (72)
Medications
Beta blockers 46 (20) 100 (23.4) 0.41
ACE inhibitors/ARBs 43 (19) 55 (13) 0.30
Statins 133 (59.5) 37 (9) < 0.001
Calcium channel blockers 4 (1.8) 12 (2.8) 0.65

a Data are shown as mean ± SD or median (interquartile range) for continuous variables and absolute numbers (percentage) for dichotomous variables.

b Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; and UA, unstable angina.